The Hippo signaling pathway is a recently identified tumor suppressor pathway, which imposes significant impact on HCC progression primarily by inhibiting HCC cell proliferation and suppressing the transcriptional activity of YAP/TAZ through two Hippo kinases, Mst1 and Mst2 [87]. The gene discussed is STK3; the disease is hepatocellular carcinoma.